When distinguishing NSCLC from BPN, the combined diagnosis of anti-COPT1-IgG, anti-COPT1-IgM and CEA enhanced the accuracy of NSCLC detection with AUC of 0.670. The gene discussed is CEACAM5; the disease is non-small cell lung carcinoma.